INDIAN JOURNAL OF BIOCHEMISTRY & BIOPHYSICS is a well-regarded academic journal that serves as a vital platform for researchers in the fields of biochemistry and biophysics. Published by the NATL INST SCIENCE COMMUNICATION-NISCAIR since its inception in 1972, this Open Access journal has committed itself to disseminating high-quality research and advancements in these dynamic fields, allowing readers worldwide to access vital findings since 2009. The journal maintains a robust presence in the academic landscape, achieving noteworthy rankings in 2023, placing it in the Q4 category for Biochemistry and Q3 for both Biophysics and miscellaneous Medicine, alongside its respectable Scopus rankings. With an emphasis on original research articles, reviews, and educational contributions, the INDIAN JOURNAL OF BIOCHEMISTRY & BIOPHYSICS plays an essential role in fostering scientific dialogue and collaboration among professionals and students alike. For scholars seeking to stay at the forefront of biochemistry and biophysics research, this journal is an indispensable resource that fosters knowledge exchange and elevates the field on both a national and international scale.

Chem-Bio Informatics Journal is a dedicated platform for the dissemination of innovative research in the intersecting realms of biochemistry and computational science. Published by the CHEM-BIO INFORMATICS SOC in Japan, this journal embraces the rapidly evolving field of chemoinformatics and bioinformatics, fostering scholarly communication among researchers, professionals, and students alike. With its ISSN: 1347-6297 and E-ISSN: 1347-0442, the journal continues to enrich the scientific community by offering insights into novel methodologies and applications that bridge chemistry and biology. Although currently positioned in the fourth quartile in the biochemistry category according to Scopus rankings, contributing to this journal provides an invaluable opportunity for authors to showcase impactful findings that could resonate within the field. The journal is particularly committed to supporting interdisciplinary research that addresses complex biological problems through computational modeling and data analysis. By publishing high-quality and peer-reviewed articles, Chem-Bio Informatics Journal aims to enhance the scientific discourse and is poised to become a pivotal resource for advancing the frontiers of biochemistry and molecular biology.

Chemical Biology & Drug Design, an esteemed publication by WILEY, serves as a vital platform for the dissemination of pioneering research in the interdisciplinary fields of biochemistry, drug discovery, molecular medicine, organic chemistry, and pharmacology. With a dedicated commitment to advancing the understanding of chemical interactions and drug development, this journal not only fosters innovation but also bridges the gap between theoretical research and practical applications. It boasts an impressive impact factor and is recognized in the 2023 category quartiles as Q3 in Biochemistry and Molecular Medicine, and Q2 in Drug Discovery, Organic Chemistry, and Pharmacology, indicating its relevance and influence in these crucial areas. The journal’s rankings across various Scopus categories further solidify its position as a reputable resource for researchers, professionals, and students striving to stay at the forefront of medicinal chemistry and drug design. While primarily traditional access-based, the journal's evolving scope from 2006 to 2024 ensures an ongoing contribution to essential scientific dialogue, making it an indispensable read for those committed to advancing health sciences.

Molecular Informatics is a prestigious journal published by WILEY-V C H VERLAG GMBH, dedicated to advancing the fields of computational analysis and molecular modeling. As a key resource in the realms of Computer Science Applications, Drug Discovery, Molecular Medicine, Organic Chemistry, and Structural Biology, this journal is recognized for its significant contributions and is ranked in the Q2 and Q3 categories across multiple disciplines, positioning it among the leading journals for researchers and academics. With an impressive track record since its inception in 2010 and converging its contributions until 2024, Molecular Informatics aims to bridge the gap between computational techniques and biological applications, promoting interdisciplinary collaboration and innovation. Accessible to a global audience, the journal reflects a commitment to advancing science through open access options, making cutting-edge research available to students, professionals, and decision-makers alike. This journal serves as an indispensable platform for disseminating high-quality research and fostering the development of new theoretical and practical frameworks in molecular informatics.

IUCrJ, published by the International Union of Crystallography, is a leading open-access journal dedicated to advancing knowledge in the fields of Biochemistry, Chemistry, Condensed Matter Physics, and Materials Science. Since its inception in 2014, IUCrJ has quickly established itself as a prestigious platform for high-quality research, achieving a remarkable record as a Q1 journal across its categories in 2023. With an increasing impact in the scientific community, evidenced by impressive Scopus rankings, IUCrJ offers unparalleled access to groundbreaking discoveries and methodologies that contribute to the understanding and application of crystallography in various disciplines. The journal’s commitment to open access ensures that research is readily available to a global audience, fostering collaboration and innovation in the scientific community. IUCrJ is an essential resource for researchers, professionals, and students aiming to stay at the forefront of crystallographic research and its interdisciplinary applications.

BIOPHYSICAL CHEMISTRY, published by Elsevier, is a prestigious journal with a long-standing tradition since its inception in 1973. This highly respected journal focuses on the intersections of biochemistry, biophysics, and organic chemistry, providing a critical platform for researchers, professionals, and students to disseminate pivotal findings in these dynamic fields. With an impressive impact factor that reflects its robust academic influence and high citation rates, it ranks within the Q2 quartile among its peers in multiple categories, indicating its significance in the scholarly community. The journal, hosted in the Netherlands, encompasses a diverse range of topics, from molecular interactions to protein folding, and serves as an essential resource for those engaged in cutting-edge research. Researchers looking to share their work with a global audience will find BIOPHYSICAL CHEMISTRY an invaluable outlet, fostering the advancement of knowledge in this crucial area of science. For more information, visit the journal's page on the Elsevier platform.

Interdisciplinary Sciences-Computational Life Sciences, published by SPRINGER HEIDELBERG, is a premier journal dedicated to advancing the field of life sciences through the lens of computational methods. With an ISSN of 1913-2751 and an E-ISSN of 1867-1462, this journal serves as a significant platform for researchers and professionals alike, fostering innovation and collaboration across various disciplines. As a testament to its impact, the journal holds a Q2 category status in Biochemistry, Genetics and Molecular Biology, Computer Science Applications, and Health Informatics, reflecting its influential contributions and rigorous peer-review process. The Scopus rankings demonstrate its esteemed placement within its fields, with notable percentiles that highlight its relevance and reach. While the journal operates under a traditional access model, its commitment to publishing high-quality research continues to stimulate important discussions and developments within the scientific community. Founded in 2009 and converging through 2024, Interdisciplinary Sciences-Computational Life Sciences remains an essential resource for the latest discoveries at the intersection of computation and life sciences, appealing to both seasoned researchers and enthusiastic students eager to contribute to this dynamic field.

CELL BIOCHEMISTRY AND BIOPHYSICS is a distinguished journal published by HUMANA PRESS INC, focusing on critical advancements in the fields of biochemistry, biophysics, and cell biology. Since its establishment, the journal has provided a robust platform for the dissemination of cutting-edge research, covering diverse aspects of cellular biochemistry and the physical principles that underlie biological systems. With an emphasis on interdisciplinary studies, the journal aims to facilitate knowledge exchange among researchers, professionals, and students from various scientific backgrounds. As reflected in its 2023 category rankings, it holds a respectable position in Q3 for Biochemistry and Cell Biology, and Q2 for both Biophysics and Medicine (miscellaneous), indicating its significant contribution to these fields. Although it operates under a subscription model, the journal's commitment to maintaining high publication standards ensures that only impactful studies are shared with its audience. With a range of articles spanning theoretical insights to practical applications, CELL BIOCHEMISTRY AND BIOPHYSICS is an essential resource for those aiming to stay at the forefront of biochemical and biophysical research.

Current Computer-Aided Drug Design, published by BENTHAM SCIENCE PUBL LTD, is a pivotal journal dedicated to the integration of computer-aided methodologies within the drug design process. With its ISSN 1573-4099 and E-ISSN 1875-6697, this journal serves as a vital resource for researchers, professionals, and students interested in advancing the fields of pharmacology and molecular medicine. Operating under a framework that spans from 2006 to 2024, it aims to foster innovative approaches and discussions surrounding drug design strategies, computational techniques, and the therapeutic potential of novel compounds. Although it currently holds a Q4 rating in Drug Discovery and Molecular Medicine as well as a Q3 in Medicine (miscellaneous) within the 2023 category quartiles, the journal continues to enhance its visibility and relevance in the academic community. Its Scopus rankings reflect its commitment to quality research, positioning it in the context of drug discovery and molecular studies. As the field of drug design evolves, Current Computer-Aided Drug Design remains an essential platform for disseminating cutting-edge findings and facilitating collaboration among specialists aiming for significant advancements in drug development.

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, published by Taylor & Francis Ltd, is a premier open-access journal that has been at the forefront of research in the field of medicinal chemistry since its inception in 1985. With an ISSN of 1475-6366 and an E-ISSN of 1475-6374, this journal boasts a prestigious reputation reflected in its impressive Q1 rankings across critical categories such as Drug Discovery and Pharmacology as of 2023. Situated in the United Kingdom, it plays a vital role in disseminating high-quality research that addresses the burgeoning needs of drug discovery and enzyme inhibition methodologies. The journal supports full open access, providing a platform for researchers, professionals, and students to share significant findings and innovations widely. With a robust impact factor, the JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY is indispensable for any academic or professional involved in the pharmacological sciences, offering an unparalleled insight into the latest advancements in therapeutic strategies and drug development.